The amount of weight loss you can expect from appetite suppression with semaglutide GLP-1 varies depending on individual factors such as your starting weight, lifestyle, and adherence to the treatment plan
The 2025 WHO guideline likewise addresses three agents for long-term treatment of obesity in adults: liraglutide, semaglutide and tirzepatide
Compounded options are not FDA-approved finished drug products, and their availability in 2026 is actively subject to regulatory change
Through appetite suppression, increased satiety, and reduced caloric intake, semaglutide aids in achieving sustainable weight loss goals and improving overall metabolic health
It is needed for surgeries, cancer treatments, chronic illnesses, and traumatic injuries
If history is any guide, including the results of similar litigation brought by Novo against generic drug manufacturers, such litigation will most likely end in a settlement, with minimal if any negative consequences for Hims